We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$289M
1-Year Est. Return
30.86%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$233M
AUM Growth
+$3.34M
(+1.5%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
71.03%
Holding
65
New
7
Increased
7
Reduced
23
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$383K |
| 2 |
NVIDIA
NVDA
|
+$226K |
| 3 |
Symbotic
SYM
|
+$224K |
| 4 |
Boeing
BA
|
+$221K |
| 5 |
Rio Tinto
RIO
|
+$214K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.17M |
| 2 |
Intuitive Surgical
ISRG
|
+$1.46M |
| 3 |
Idexx Laboratories
IDXX
|
+$1.18M |
| 4 |
Tompkins Financial
TMP
|
+$1.04M |
| 5 |
AT&T
T
|
+$924K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.38% |
| 2 | Healthcare | 30.59% |
| 3 | Communication Services | 10.26% |
| 4 | Industrials | 5.75% |
| 5 | Consumer Discretionary | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Southern Company
SO
$107B
| $281K | 0.12% |
3,931
| – | – |
|
52
Stryker
SYK
$130B
| $265K | 0.11% |
1,084
| – | – |
|
53
Littelfuse
LFUS
$11.6B
| $264K | 0.11% |
1,200
| – | – |
|
|
54
Boeing
BA
$185B
| $257K | 0.11% |
+1,350
| New | +$221K |
|
55
Consolidated Edison
ED
$39.9B
| $253K | 0.11% |
2,650
| – | – |
|
56
Cognizant
CTSH
$26B
| $246K | 0.11% |
4,300
-150
| -3% | -$8.8K |
|
|
57
Rio Tinto
RIO
$164B
| $242K | 0.1% |
+3,400
| New | +$214K |
|
58
Wayfair
W
$14.6B
| $238K | 0.1% |
7,229
| – | – |
|
59
Hormel Foods
HRL
$13.8B
| $235K | 0.1% |
5,150
| – | – |
|
|
60
Symbotic
SYM
$5.22B
| $229K | 0.1% |
+19,210
| New | +$224K |
|
|
61
NVIDIA
NVDA
$5.42T
| $226K | 0.1% |
+15,440
| New | +$226K |
|
62
IBM
IBM
$224B
| $207K | 0.09% |
+1,470
| New | +$203K |
|
63
JPMorgan Chase
JPM
$950B
| $201K | 0.09% |
+1,500
| New | +$190K |
|
64
Catheter Precision
VTAK
$1.01M
| – | – |
-4
| Closed | -$4K |
|
65
Warner Bros
WBD
$67.1B
| – | – |
-22,683
| Closed | -$261K |
|
Similar funds
PIA
CCC
GIM
PSA
SI
FFA
OCM
ODFS
Bourne Lent Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Bourne Lent Asset Management held 65 positions worth $233M, up 1.5% from $230M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Bourne Lent Asset Management withdrew a net $13.5M in Q4 2022, closing 2 positions and reducing 23 holdings. Its most notable exit was Warner Bros, an estimated $261K position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bourne Lent Asset Management opened a new position in SPDR Gold Trust worth $403K.
- Bourne Lent Asset Management's largest Q4 2022 buy was SPDR Gold Trust: 2,375 shares worth $403K.
- Bourne Lent Asset Management added most to Pacific Biosciences in Q4 2022, an estimated $62.9K increase.
- Bourne Lent Asset Management's biggest Q4 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.17M.
- Bourne Lent Asset Management fully exited Warner Bros in Q4 2022, selling an estimated $261K.
- Bourne Lent Asset Management's ten largest holdings make up 71% of its $233M portfolio in Q4 2022.
- Bourne Lent Asset Management opened 7 new positions and closed 2 in Q4 2022.
- Bourne Lent Asset Management's portfolio value rose 1.5% quarter-over-quarter to $233M.
Based on Bourne Lent Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.